Female contraceptives, also known as female birth control are methods of preventing pregnancy that primarily involve the female physiology.
Female contraceptive devices account for major shares of the contraceptive pills market throughout the forecast period. The increasing adoption of female contraceptive devices will drive the growth of this product segment in the female contraceptive market.
Market Analysis and Insights: Global Female Contraceptive Market
The global Female Contraceptive market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Female Contraceptive Scope and Segment
The global Female Contraceptive market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Female Contraceptive market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Female Contraceptive Devices
Female Contraceptive Drugs
By the end users/application, this report covers the following segments
Online Stores
Retail Outlets
Competitive Landscape:
The report provides a list of all the key players in the Female Contraceptive market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Female Contraceptive key manufacturers in this market include:
Merck
Pfizer
Allergan
Bayer
Okamoto Industries
Reckitt Benckiser
Lupin Pharmaceuticals
Foundation Consumer Healthcare
Teva Pharmaceuticals
Ansell
Ferring Pharmaceuticals
Fuji Latex
Janssen Pharmaceuticals
Female contraceptive devices account for major shares of the contraceptive pills market throughout the forecast period. The increasing adoption of female contraceptive devices will drive the growth of this product segment in the female contraceptive market.
Market Analysis and Insights: Global Female Contraceptive Market
The global Female Contraceptive market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Female Contraceptive Scope and Segment
The global Female Contraceptive market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Female Contraceptive market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Female Contraceptive Devices
Female Contraceptive Drugs
By the end users/application, this report covers the following segments
Online Stores
Retail Outlets
Competitive Landscape:
The report provides a list of all the key players in the Female Contraceptive market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Female Contraceptive key manufacturers in this market include:
Merck
Pfizer
Allergan
Bayer
Okamoto Industries
Reckitt Benckiser
Lupin Pharmaceuticals
Foundation Consumer Healthcare
Teva Pharmaceuticals
Ansell
Ferring Pharmaceuticals
Fuji Latex
Janssen Pharmaceuticals
1 Female Contraceptive Market Overview
1.1 Female Contraceptive Product Overview
1.2 Female Contraceptive Market Segment by Type
1.2.1 Female Contraceptive Devices
1.2.2 Female Contraceptive Drugs
1.3 Global Female Contraceptive Market Size by Type
1.3.1 Global Female Contraceptive Market Size Overview by Type (2016-2027)
1.3.2 Global Female Contraceptive Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Female Contraceptive Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Female Contraceptive Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Female Contraceptive Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Female Contraceptive Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Female Contraceptive Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Female Contraceptive Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Female Contraceptive Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Female Contraceptive Sales Breakdown by Type (2016-2021)
1.4.2 Europe Female Contraceptive Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Female Contraceptive Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Female Contraceptive Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Female Contraceptive Sales Breakdown by Type (2016-2021)
2 Global Female Contraceptive Market Competition by Company
2.1 Global Top Players by Female Contraceptive Sales (2016-2021)
2.2 Global Top Players by Female Contraceptive Revenue (2016-2021)
2.3 Global Top Players Female Contraceptive Price (2016-2021)
2.4 Global Top Manufacturers Female Contraceptive Manufacturing Base Distribution, Sales Area, Product Type
2.5 Female Contraceptive Market Competitive Situation and Trends
2.5.1 Female Contraceptive Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Female Contraceptive Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Female Contraceptive as of 2020)
2.7 Date of Key Manufacturers Enter into Female Contraceptive Market
2.8 Key Manufacturers Female Contraceptive Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Female Contraceptive Status and Outlook by Region
3.1 Global Female Contraceptive Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Female Contraceptive Historic Market Size by Region
3.2.1 Global Female Contraceptive Sales in Volume by Region (2016-2021)
3.2.2 Global Female Contraceptive Sales in Value by Region (2016-2021)
3.2.3 Global Female Contraceptive Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Female Contraceptive Forecasted Market Size by Region
3.3.1 Global Female Contraceptive Sales in Volume by Region (2022-2027)
3.3.2 Global Female Contraceptive Sales in Value by Region (2022-2027)
3.3.3 Global Female Contraceptive Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Female Contraceptive by Application
4.1 Female Contraceptive Market Segment by Application
4.1.1 Online Stores
4.1.2 Retail Outlets
4.2 Global Female Contraceptive Market Size by Application
4.2.1 Global Female Contraceptive Market Size Overview by Application (2016-2027)
4.2.2 Global Female Contraceptive Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Female Contraceptive Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Female Contraceptive Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Female Contraceptive Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Female Contraceptive Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Female Contraceptive Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Female Contraceptive Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Female Contraceptive Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Female Contraceptive Sales Breakdown by Application (2016-2021)
4.3.2 Europe Female Contraceptive Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Female Contraceptive Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Female Contraceptive Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Female Contraceptive Sales Breakdown by Application (2016-2021)
5 North America Female Contraceptive by Country
5.1 North America Female Contraceptive Historic Market Size by Country
5.1.1 North America Female Contraceptive Sales in Volume by Country (2016-2021)
5.1.2 North America Female Contraceptive Sales in Value by Country (2016-2021)
5.2 North America Female Contraceptive Forecasted Market Size by Country
5.2.1 North America Female Contraceptive Sales in Volume by Country (2022-2027)
5.2.2 North America Female Contraceptive Sales in Value by Country (2022-2027)
6 Europe Female Contraceptive by Country
6.1 Europe Female Contraceptive Historic Market Size by Country
6.1.1 Europe Female Contraceptive Sales in Volume by Country (2016-2021)
6.1.2 Europe Female Contraceptive Sales in Value by Country (2016-2021)
6.2 Europe Female Contraceptive Forecasted Market Size by Country
6.2.1 Europe Female Contraceptive Sales in Volume by Country (2022-2027)
6.2.2 Europe Female Contraceptive Sales in Value by Country (2022-2027)
7 Asia-Pacific Female Contraceptive by Region
7.1 Asia-Pacific Female Contraceptive Historic Market Size by Region
7.1.1 Asia-Pacific Female Contraceptive Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Female Contraceptive Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Female Contraceptive Forecasted Market Size by Region
7.2.1 Asia-Pacific Female Contraceptive Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Female Contraceptive Sales in Value by Region (2022-2027)
8 Latin America Female Contraceptive by Country
8.1 Latin America Female Contraceptive Historic Market Size by Country
8.1.1 Latin America Female Contraceptive Sales in Volume by Country (2016-2021)
8.1.2 Latin America Female Contraceptive Sales in Value by Country (2016-2021)
8.2 Latin America Female Contraceptive Forecasted Market Size by Country
8.2.1 Latin America Female Contraceptive Sales in Volume by Country (2022-2027)
8.2.2 Latin America Female Contraceptive Sales in Value by Country (2022-2027)
9 Middle East and Africa Female Contraceptive by Country
9.1 Middle East and Africa Female Contraceptive Historic Market Size by Country
9.1.1 Middle East and Africa Female Contraceptive Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Female Contraceptive Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Female Contraceptive Forecasted Market Size by Country
9.2.1 Middle East and Africa Female Contraceptive Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Female Contraceptive Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Female Contraceptive Business
10.1 Merck
10.1.1 Merck Corporation Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Merck Female Contraceptive Products Offered
10.1.5 Merck Recent Development
10.2 Pfizer
10.2.1 Pfizer Corporation Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Merck Female Contraceptive Products Offered
10.2.5 Pfizer Recent Development
10.3 Allergan
10.3.1 Allergan Corporation Information
10.3.2 Allergan Introduction and Business Overview
10.3.3 Allergan Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Allergan Female Contraceptive Products Offered
10.3.5 Allergan Recent Development
10.4 Bayer
10.4.1 Bayer Corporation Information
10.4.2 Bayer Introduction and Business Overview
10.4.3 Bayer Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Bayer Female Contraceptive Products Offered
10.4.5 Bayer Recent Development
10.5 Okamoto Industries
10.5.1 Okamoto Industries Corporation Information
10.5.2 Okamoto Industries Introduction and Business Overview
10.5.3 Okamoto Industries Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Okamoto Industries Female Contraceptive Products Offered
10.5.5 Okamoto Industries Recent Development
10.6 Reckitt Benckiser
10.6.1 Reckitt Benckiser Corporation Information
10.6.2 Reckitt Benckiser Introduction and Business Overview
10.6.3 Reckitt Benckiser Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Reckitt Benckiser Female Contraceptive Products Offered
10.6.5 Reckitt Benckiser Recent Development
10.7 Lupin Pharmaceuticals
10.7.1 Lupin Pharmaceuticals Corporation Information
10.7.2 Lupin Pharmaceuticals Introduction and Business Overview
10.7.3 Lupin Pharmaceuticals Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Lupin Pharmaceuticals Female Contraceptive Products Offered
10.7.5 Lupin Pharmaceuticals Recent Development
10.8 Foundation Consumer Healthcare
10.8.1 Foundation Consumer Healthcare Corporation Information
10.8.2 Foundation Consumer Healthcare Introduction and Business Overview
10.8.3 Foundation Consumer Healthcare Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Foundation Consumer Healthcare Female Contraceptive Products Offered
10.8.5 Foundation Consumer Healthcare Recent Development
10.9 Teva Pharmaceuticals
10.9.1 Teva Pharmaceuticals Corporation Information
10.9.2 Teva Pharmaceuticals Introduction and Business Overview
10.9.3 Teva Pharmaceuticals Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Teva Pharmaceuticals Female Contraceptive Products Offered
10.9.5 Teva Pharmaceuticals Recent Development
10.10 Ansell
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Female Contraceptive Product Category, Application and Specification
10.10.3 Ansell Female Contraceptive Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Ansell Recent Development
10.11 Ferring Pharmaceuticals
10.11.1 Ferring Pharmaceuticals Corporation Information
10.11.2 Ferring Pharmaceuticals Introduction and Business Overview
10.11.3 Ferring Pharmaceuticals Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Ferring Pharmaceuticals Female Contraceptive Products Offered
10.11.5 Ferring Pharmaceuticals Recent Development
10.12 Fuji Latex
10.12.1 Fuji Latex Corporation Information
10.12.2 Fuji Latex Introduction and Business Overview
10.12.3 Fuji Latex Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Fuji Latex Female Contraceptive Products Offered
10.12.5 Fuji Latex Recent Development
10.13 Janssen Pharmaceuticals
10.13.1 Janssen Pharmaceuticals Corporation Information
10.13.2 Janssen Pharmaceuticals Introduction and Business Overview
10.13.3 Janssen Pharmaceuticals Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Janssen Pharmaceuticals Female Contraceptive Products Offered
10.13.5 Janssen Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Female Contraceptive Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Female Contraceptive Industrial Chain Analysis
11.4 Female Contraceptive Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Female Contraceptive Distributors
12.3 Female Contraceptive Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Female Contraceptive Product Overview
1.2 Female Contraceptive Market Segment by Type
1.2.1 Female Contraceptive Devices
1.2.2 Female Contraceptive Drugs
1.3 Global Female Contraceptive Market Size by Type
1.3.1 Global Female Contraceptive Market Size Overview by Type (2016-2027)
1.3.2 Global Female Contraceptive Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Female Contraceptive Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Female Contraceptive Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Female Contraceptive Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Female Contraceptive Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Female Contraceptive Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Female Contraceptive Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Female Contraceptive Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Female Contraceptive Sales Breakdown by Type (2016-2021)
1.4.2 Europe Female Contraceptive Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Female Contraceptive Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Female Contraceptive Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Female Contraceptive Sales Breakdown by Type (2016-2021)
2 Global Female Contraceptive Market Competition by Company
2.1 Global Top Players by Female Contraceptive Sales (2016-2021)
2.2 Global Top Players by Female Contraceptive Revenue (2016-2021)
2.3 Global Top Players Female Contraceptive Price (2016-2021)
2.4 Global Top Manufacturers Female Contraceptive Manufacturing Base Distribution, Sales Area, Product Type
2.5 Female Contraceptive Market Competitive Situation and Trends
2.5.1 Female Contraceptive Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Female Contraceptive Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Female Contraceptive as of 2020)
2.7 Date of Key Manufacturers Enter into Female Contraceptive Market
2.8 Key Manufacturers Female Contraceptive Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Female Contraceptive Status and Outlook by Region
3.1 Global Female Contraceptive Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Female Contraceptive Historic Market Size by Region
3.2.1 Global Female Contraceptive Sales in Volume by Region (2016-2021)
3.2.2 Global Female Contraceptive Sales in Value by Region (2016-2021)
3.2.3 Global Female Contraceptive Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Female Contraceptive Forecasted Market Size by Region
3.3.1 Global Female Contraceptive Sales in Volume by Region (2022-2027)
3.3.2 Global Female Contraceptive Sales in Value by Region (2022-2027)
3.3.3 Global Female Contraceptive Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Female Contraceptive by Application
4.1 Female Contraceptive Market Segment by Application
4.1.1 Online Stores
4.1.2 Retail Outlets
4.2 Global Female Contraceptive Market Size by Application
4.2.1 Global Female Contraceptive Market Size Overview by Application (2016-2027)
4.2.2 Global Female Contraceptive Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Female Contraceptive Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Female Contraceptive Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Female Contraceptive Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Female Contraceptive Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Female Contraceptive Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Female Contraceptive Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Female Contraceptive Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Female Contraceptive Sales Breakdown by Application (2016-2021)
4.3.2 Europe Female Contraceptive Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Female Contraceptive Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Female Contraceptive Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Female Contraceptive Sales Breakdown by Application (2016-2021)
5 North America Female Contraceptive by Country
5.1 North America Female Contraceptive Historic Market Size by Country
5.1.1 North America Female Contraceptive Sales in Volume by Country (2016-2021)
5.1.2 North America Female Contraceptive Sales in Value by Country (2016-2021)
5.2 North America Female Contraceptive Forecasted Market Size by Country
5.2.1 North America Female Contraceptive Sales in Volume by Country (2022-2027)
5.2.2 North America Female Contraceptive Sales in Value by Country (2022-2027)
6 Europe Female Contraceptive by Country
6.1 Europe Female Contraceptive Historic Market Size by Country
6.1.1 Europe Female Contraceptive Sales in Volume by Country (2016-2021)
6.1.2 Europe Female Contraceptive Sales in Value by Country (2016-2021)
6.2 Europe Female Contraceptive Forecasted Market Size by Country
6.2.1 Europe Female Contraceptive Sales in Volume by Country (2022-2027)
6.2.2 Europe Female Contraceptive Sales in Value by Country (2022-2027)
7 Asia-Pacific Female Contraceptive by Region
7.1 Asia-Pacific Female Contraceptive Historic Market Size by Region
7.1.1 Asia-Pacific Female Contraceptive Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Female Contraceptive Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Female Contraceptive Forecasted Market Size by Region
7.2.1 Asia-Pacific Female Contraceptive Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Female Contraceptive Sales in Value by Region (2022-2027)
8 Latin America Female Contraceptive by Country
8.1 Latin America Female Contraceptive Historic Market Size by Country
8.1.1 Latin America Female Contraceptive Sales in Volume by Country (2016-2021)
8.1.2 Latin America Female Contraceptive Sales in Value by Country (2016-2021)
8.2 Latin America Female Contraceptive Forecasted Market Size by Country
8.2.1 Latin America Female Contraceptive Sales in Volume by Country (2022-2027)
8.2.2 Latin America Female Contraceptive Sales in Value by Country (2022-2027)
9 Middle East and Africa Female Contraceptive by Country
9.1 Middle East and Africa Female Contraceptive Historic Market Size by Country
9.1.1 Middle East and Africa Female Contraceptive Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Female Contraceptive Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Female Contraceptive Forecasted Market Size by Country
9.2.1 Middle East and Africa Female Contraceptive Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Female Contraceptive Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Female Contraceptive Business
10.1 Merck
10.1.1 Merck Corporation Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Merck Female Contraceptive Products Offered
10.1.5 Merck Recent Development
10.2 Pfizer
10.2.1 Pfizer Corporation Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Merck Female Contraceptive Products Offered
10.2.5 Pfizer Recent Development
10.3 Allergan
10.3.1 Allergan Corporation Information
10.3.2 Allergan Introduction and Business Overview
10.3.3 Allergan Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Allergan Female Contraceptive Products Offered
10.3.5 Allergan Recent Development
10.4 Bayer
10.4.1 Bayer Corporation Information
10.4.2 Bayer Introduction and Business Overview
10.4.3 Bayer Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Bayer Female Contraceptive Products Offered
10.4.5 Bayer Recent Development
10.5 Okamoto Industries
10.5.1 Okamoto Industries Corporation Information
10.5.2 Okamoto Industries Introduction and Business Overview
10.5.3 Okamoto Industries Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Okamoto Industries Female Contraceptive Products Offered
10.5.5 Okamoto Industries Recent Development
10.6 Reckitt Benckiser
10.6.1 Reckitt Benckiser Corporation Information
10.6.2 Reckitt Benckiser Introduction and Business Overview
10.6.3 Reckitt Benckiser Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Reckitt Benckiser Female Contraceptive Products Offered
10.6.5 Reckitt Benckiser Recent Development
10.7 Lupin Pharmaceuticals
10.7.1 Lupin Pharmaceuticals Corporation Information
10.7.2 Lupin Pharmaceuticals Introduction and Business Overview
10.7.3 Lupin Pharmaceuticals Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Lupin Pharmaceuticals Female Contraceptive Products Offered
10.7.5 Lupin Pharmaceuticals Recent Development
10.8 Foundation Consumer Healthcare
10.8.1 Foundation Consumer Healthcare Corporation Information
10.8.2 Foundation Consumer Healthcare Introduction and Business Overview
10.8.3 Foundation Consumer Healthcare Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Foundation Consumer Healthcare Female Contraceptive Products Offered
10.8.5 Foundation Consumer Healthcare Recent Development
10.9 Teva Pharmaceuticals
10.9.1 Teva Pharmaceuticals Corporation Information
10.9.2 Teva Pharmaceuticals Introduction and Business Overview
10.9.3 Teva Pharmaceuticals Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Teva Pharmaceuticals Female Contraceptive Products Offered
10.9.5 Teva Pharmaceuticals Recent Development
10.10 Ansell
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Female Contraceptive Product Category, Application and Specification
10.10.3 Ansell Female Contraceptive Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Ansell Recent Development
10.11 Ferring Pharmaceuticals
10.11.1 Ferring Pharmaceuticals Corporation Information
10.11.2 Ferring Pharmaceuticals Introduction and Business Overview
10.11.3 Ferring Pharmaceuticals Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Ferring Pharmaceuticals Female Contraceptive Products Offered
10.11.5 Ferring Pharmaceuticals Recent Development
10.12 Fuji Latex
10.12.1 Fuji Latex Corporation Information
10.12.2 Fuji Latex Introduction and Business Overview
10.12.3 Fuji Latex Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Fuji Latex Female Contraceptive Products Offered
10.12.5 Fuji Latex Recent Development
10.13 Janssen Pharmaceuticals
10.13.1 Janssen Pharmaceuticals Corporation Information
10.13.2 Janssen Pharmaceuticals Introduction and Business Overview
10.13.3 Janssen Pharmaceuticals Female Contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Janssen Pharmaceuticals Female Contraceptive Products Offered
10.13.5 Janssen Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Female Contraceptive Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Female Contraceptive Industrial Chain Analysis
11.4 Female Contraceptive Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Female Contraceptive Distributors
12.3 Female Contraceptive Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
